SCHEMBL4455663

SCHEMBL4455663

O=C(O)/C(=C\c1ccc(Cl)cc1[N+](=O)[O-])c1ccc(Br)cc1

nearest known ligand 0.61

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 4/20 0.42
ALDH1A1 P00352 1/20 0.40
HTT P42858 1/20 0.40
AKR1C2 P52895 1/20 0.40
AKR1C1 Q04828 1/20 0.40
ABL1 P00519 2/20 0.39
BCR P11274 2/20 0.39
FLT1 P17948 1/20 0.38
FLT4 P35916 1/20 0.38
KDR P35968 1/20 0.38
APP P05067 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1758388 1.00 AKR1C3 (0.42) AKR1C3ALDH1A1HTTAKR1C2AKR1C1
SCHEMBL1758384 1.00 AKR1C3 (0.42) AKR1C3ALDH1A1HTTAKR1C2AKR1C1
SCHEMBL2844597 0.82 MEN1 (0.49) AKR1C3ALDH1A1AKR1C1MEN1KMT2A
SCHEMBL3778274 0.82 MEN1 (0.49) AKR1C3ALDH1A1AKR1C1MEN1KMT2A
SCHEMBL1758234 0.79 HTT (0.43) AKR1C3ALDH1A1HTTAKR1C2AKR1C1
SCHEMBL1758233 0.79 HTT (0.43) AKR1C3ALDH1A1HTTAKR1C2AKR1C1
SCHEMBL5125335 0.79 HTT (0.43) AKR1C3ALDH1A1HTTAKR1C2AKR1C1
SCHEMBL11224609 0.71 MAOB (0.59) ALDH1A1AKR1C1MEN1KMT2A
SCHEMBL11224613 0.71 MAOB (0.59) ALDH1A1AKR1C1MEN1KMT2A
SCHEMBL11224607 0.71 MAOB (0.59) ALDH1A1AKR1C1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2019675-A1 METHODS FOR TREATING OR PREVENTING NEOPLASIAS Merck Frosst Canada Ltd. (CA) 2009-02-04 EP disclosed
EP-1954653-A2 METHOD OF GENERATING AMORPHOUS SOLID FOR WATER-INSOLUBLE PHARMACEUTICALS Merck & Co., Inc. (US) 2008-08-13 EP disclosed
WO-2007124589-A1 METHODS FOR TREATING OR PREVENTING NEOPLASIAS MERCK FROSST CANADA LTD. (CA) 2007-11-08 WO disclosed
WO-2007061849-A2 METHOD OF GENERATING AMORPHOUS SOLID FOR WATER-INSOLUBLE PHARMACEUTICALS MERCK & CO., INC. (US) 2007-05-31 WO disclosed